Calyxt, Inc. (CLXT): Price and Financial Metrics


Calyxt, Inc. (CLXT): $3.65

0.09 (+2.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CLXT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

CLXT POWR Grades


  • CLXT scores best on the Momentum dimension, with a Momentum rank ahead of 69.13% of US stocks.
  • CLXT's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
  • CLXT ranks lowest in Quality; there it ranks in the 3rd percentile.

CLXT Stock Summary

  • Calyxt Inc's stock had its IPO on July 20, 2017, making it an older stock than merely 13.21% of US equities in our set.
  • Revenue growth over the past 12 months for Calyxt Inc comes in at 171.95%, a number that bests 96.23% of the US stocks we're tracking.
  • In terms of volatility of its share price, CLXT is more volatile than 94.33% of stocks we're observing.
  • Stocks that are quantitatively similar to CLXT, based on their financial statements, market capitalization, and price volatility, are SPNE, XENE, MPX, UAMY, and VMI.
  • CLXT's SEC filings can be seen here. And to visit Calyxt Inc's official web site, go to www.calyxt.com.

CLXT Valuation Summary

  • In comparison to the median Consumer Defensive stock, CLXT's price/earnings ratio is 117.43% lower, now standing at -3.6.
  • CLXT's price/sales ratio has moved down 717.5 over the prior 49 months.
  • CLXT's EV/EBIT ratio has moved up 19.9 over the prior 49 months.

Below are key valuation metrics over time for CLXT.

Stock Date P/S P/B P/E EV/EBIT
CLXT 2020-08-27 15.4 4.0 -3.9 -4.3
CLXT 2019-01-23 891.2 3.7 -14.2 -11.1
CLXT 2019-01-15 874.0 3.7 -14.0 -10.8
CLXT 2018-07-03 1110.6 9.6 -18.7 -17.5
CLXT 2018-02-02 1576.2 10.1 -52.0 -47.5
CLXT 2017-09-27 1707.5 89.8 -56.4 -56.2

CLXT Price Target

For more insight on analysts targets of CLXT, see our CLXT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $7.17 Average Broker Recommendation 1.5 (Moderate Buy)

CLXT Stock Price Chart Interactive Chart >

Price chart for CLXT

CLXT Price/Volume Stats

Current price $3.65 52-week high $12.43
Prev. close $3.56 52-week low $3.16
Day low $3.43 Volume 146,217
Day high $3.65 Avg. volume 273,322
50-day MA $4.26 Dividend yield N/A
200-day MA $5.52 Market Cap 135.78M

Calyxt, Inc. (CLXT) Company Bio


Calyxt, Inc., an agriculture biotechnology company, develops healthier specialty food ingredients and agricultural food crops using gene editing technology for plants. It engages in the development of high oleic soybeans, powdery mildew resistant wheat, cold storable potatoes, high fiber wheat, reduced browning potatoes, and herbicide tolerant wheat. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. The company was founded in 2010 and is based in New Brighton, Minnesota


CLXT Latest News Stream


Event/Time News Detail
Loading, please wait...

CLXT Latest Social Stream


Loading social stream, please wait...

View Full CLXT Social Stream

Latest CLXT News From Around the Web

Below are the latest news stories about Calyxt Inc that investors may wish to consider to help them evaluate CLXT as an investment opportunity.

Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended on June 30, 2021. A press release detailing these results will be issued prior to the call.

Yahoo | July 19, 2021

Calyxt Appoints Michael A. Carr as Chief Executive Officer

Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021. Mr. Carr will also serve as a member of Calyxt's Board of Directors. Mr. Carr was most recently the Vice President of M&A, Strategy, and Innovation at Darling Ingredients, Inc., a global developer and producer of sustainable natural ingredients and renewable energy.

Yahoo | July 15, 2021

Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation

Triploid Breeding Process is Calyxt''s Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp GeneticsROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CL

FinanzNachrichten | July 8, 2021

3 Under the Radar Penny Stocks With Triple-Digit Gains in Sight

Let’s take a look away from the headline-grabbing market giants, and head into the world of penny stocks. Traditionally, these were stocks priced at just pennies per share – that’s the old English copper penny, when it was 240 pence to the pound – but nowadays the ‘pennies’ are stocks with share prices under $5. The penny stocks offer retail investors a series of advantages, all connected. Their low price makes the cost of entry to the market affordable – a relatively small investment can net a large bloc of shares.

Michael Marcus on TipRanks | July 6, 2021

The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century

Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy.

Luke Lango on InvestorPlace | July 1, 2021

Read More 'CLXT' Stories Here

CLXT Price Returns

1-mo -9.88%
3-mo -32.28%
6-mo -60.13%
1-year -17.42%
3-year -78.27%
5-year N/A
YTD -13.51%
2020 -39.80%
2019 -32.34%
2018 -52.97%
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7934 seconds.